The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Burkitt Lymphoma

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Burkitt Lymphoma

 

High impact information on Burkitt Lymphoma

 

Chemical compound and disease context of Burkitt Lymphoma

 

Biological context of Burkitt Lymphoma

 

Anatomical context of Burkitt Lymphoma

 

Gene context of Burkitt Lymphoma

 

Analytical, diagnostic and therapeutic context of Burkitt Lymphoma

References

  1. Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Lombardi, L., Newcomb, E.W., Dalla-Favera, R. Cell (1987) [Pubmed]
  2. Rat c-myc oncogene is located on chromosome 7 and rearranges in immunocytomas with t(6:7) chromosomal translocation. Sümegi, J., Spira, J., Bazin, H., Szpirer, J., Levan, G., Klein, G. Nature (1983) [Pubmed]
  3. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Moss, D.J., Misko, I.S., Burrows, S.R., Burman, K., McCarthy, R., Sculley, T.B. Nature (1988) [Pubmed]
  4. Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Subramanian, C., Cotter, M.A., Robertson, E.S. Nat. Med. (2001) [Pubmed]
  5. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Gaidano, G., Ballerini, P., Gong, J.Z., Inghirami, G., Neri, A., Newcomb, E.W., Magrath, I.T., Knowles, D.M., Dalla-Favera, R. Proc. Natl. Acad. Sci. U.S.A. (1991) [Pubmed]
  6. A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) Burkitt lymphoma. Taub, R., Kelly, K., Battey, J., Latt, S., Lenoir, G.M., Tantravahi, U., Tu, Z., Leder, P. Cell (1984) [Pubmed]
  7. Differences in the incorporation of bromodeoxyuridine by human lymphoblastoid cell lines. Henderson, E.E., Strauss, B. Cell (1975) [Pubmed]
  8. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Gregory, C.D., Dive, C., Henderson, S., Smith, C.A., Williams, G.T., Gordon, J., Rickinson, A.B. Nature (1991) [Pubmed]
  9. Close link between reduction of c-myc expression by interferon and, G0/G1 arrest. Einat, M., Resnitzky, D., Kimchi, A. Nature (1985) [Pubmed]
  10. Beta-aminoaciduria in patients with Burkitt's lymphoma. Waalkes, T.P., Gehrke, C.W., Lakings, D.B., Zumwalt, R.W., Kuo, K.C., Jacobs, S.A., Borek, E. J. Natl. Cancer Inst. (1976) [Pubmed]
  11. Cure of Burkitt's lymphoma. Ten-year follow-up of 157 Ugandan patients. Ziegler, J.L., Magrath, I.T., Olweny, C.L. Lancet (1979) [Pubmed]
  12. Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. Shacter, E., Williams, J.A., Hinson, R.M., Sentürker, S., Lee, Y.J. Blood (2000) [Pubmed]
  13. Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Serafeim, A., Holder, M.J., Grafton, G., Chamba, A., Drayson, M.T., Luong, Q.T., Bunce, C.M., Gregory, C.D., Barnes, N.M., Gordon, J. Blood (2003) [Pubmed]
  14. Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies. Syed, N., Smith, P., Sullivan, A., Spender, L.C., Dyer, M., Karran, L., O'Nions, J., Allday, M., Hoffmann, I., Crawford, D., Griffin, B., Farrell, P.J., Crook, T. Blood (2006) [Pubmed]
  15. Transcription enhancer identified near the human C mu immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt lymphoma. Rabbitts, T.H., Forster, A., Baer, R., Hamlyn, P.H. Nature (1983) [Pubmed]
  16. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Madisen, L., Groudine, M. Genes Dev. (1994) [Pubmed]
  17. Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. Cutrona, G., Ulivi, M., Fais, F., Roncella, S., Ferrarini, M. J. Exp. Med. (1995) [Pubmed]
  18. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. Khanna, R., Burrows, S.R., Kurilla, M.G., Jacob, C.A., Misko, I.S., Sculley, T.B., Kieff, E., Moss, D.J. J. Exp. Med. (1992) [Pubmed]
  19. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. Gregory, C.D., Murray, R.J., Edwards, C.F., Rickinson, A.B. J. Exp. Med. (1988) [Pubmed]
  20. Repression of rearranged mu gene and translocated c-myc in mouse 3T3 cells X Burkitt lymphoma cell hybrids. Nishikura, K., ar-Rushdi, A., Erikson, J., DeJesus, E., Dugan, D., Croce, C.M. Science (1984) [Pubmed]
  21. The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles. Spencer, C.A., LeStrange, R.C., Novak, U., Hayward, W.S., Groudine, M. Genes Dev. (1990) [Pubmed]
  22. Extreme instability of myc mRNA in normal and transformed human cells. Dani, C., Blanchard, J.M., Piechaczyk, M., El Sabouty, S., Marty, L., Jeanteur, P. Proc. Natl. Acad. Sci. U.S.A. (1984) [Pubmed]
  23. Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation. Kumar, R., Atlas, I. Proc. Natl. Acad. Sci. U.S.A. (1992) [Pubmed]
  24. Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells. Croce, C.M., Erikson, J., ar-Rushdi, A., Aden, D., Nishikura, K. Proc. Natl. Acad. Sci. U.S.A. (1984) [Pubmed]
  25. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. Burdin, N., Péronne, C., Banchereau, J., Rousset, F. J. Exp. Med. (1993) [Pubmed]
  26. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. Legler, D.F., Loetscher, M., Roos, R.S., Clark-Lewis, I., Baggiolini, M., Moser, B. J. Exp. Med. (1998) [Pubmed]
  27. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor. Delcayre, A.X., Salas, F., Mathur, S., Kovats, K., Lotz, M., Lernhardt, W. EMBO J. (1991) [Pubmed]
  28. Monoclonal antibody against a Burkitt lymphoma-associated antigen. Wiels, J., Fellous, M., Tursz, T. Proc. Natl. Acad. Sci. U.S.A. (1981) [Pubmed]
  29. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity. Chen, H., Lee, J.M., Wang, Y., Huang, D.P., Ambinder, R.F., Hayward, S.D. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  30. Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity. Welte, K., Wang, C.Y., Mertelsmann, R., Venuta, S., Feldman, S.P., Moore, M.A. J. Exp. Med. (1982) [Pubmed]
  31. An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Liebowitz, D., Kopan, R., Fuchs, E., Sample, J., Kieff, E. Mol. Cell. Biol. (1987) [Pubmed]
  32. Characterization and chromosomal localization of the human proto-oncogene BMI-1. Alkema, M.J., Wiegant, J., Raap, A.K., Berns, A., van Lohuizen, M. Hum. Mol. Genet. (1993) [Pubmed]
  33. CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK/SAPK signaling cascade. Tuscano, J.M., Riva, A., Toscano, S.N., Tedder, T.F., Kehrl, J.H. Blood (1999) [Pubmed]
  34. Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon. Zani, V.J., Asou, N., Jadayel, D., Heward, J.M., Shipley, J., Nacheva, E., Takasuki, K., Catovsky, D., Dyer, M.J. Blood (1996) [Pubmed]
 
WikiGenes - Universities